ArticleInfection and immunity1995
Monoclonal antibodies specific for the bundle-forming pilus of enteropathogenic Escherichia coli.
Article in Infection and immunity, 1995. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 21 citations in OpenAlex.
- Diarrheagenic Escherichia coli.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2016Review
- Monoclonal antibodies against all known variants of EspA: development of a simple diagnostic test for enteropathogenic Escherichia coli based on a key virulence factor.Journal of medical microbiology · 2014Article
- Virulence of enteropathogenic Escherichia coli, a global pathogen.Clinical microbiology reviews · 2003Review
- Expression of the bundle-forming pilus by enteropathogenic Escherichia coli strains of heterologous serotypes.Journal of clinical microbiology · 2002Article
- Characterization of enteropathogenic and enteroaggregative Escherichia coli isolated from diarrheal outbreaks.Journal of clinical microbiology · 2002Article
- Novel topology of BfpE, a cytoplasmic membrane protein required for type IV fimbrial biogenesis in enteropathogenic Escherichia coli.Journal of bacteriology · 2001Article
- Molecular variation among type IV pilin (bfpA) genes from diverse enteropathogenic Escherichia coli strains.Infection and immunity · 2000Article
- Identification of enterotoxigenic Escherichia coli harboring longus type IV pilus gene by DNA amplification.Journal of clinical microbiology · 2000Article
- Effects of bfp mutations on biogenesis of functional enteropathogenic Escherichia coli type IV pili.Journal of bacteriology · 2000Article
- Diarrheagenic Escherichia coli.Clinical microbiology reviews · 1998Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
Abstract
The bundle-forming pilus (BFP) produced by enteropathogenic Escherichia coli (EPEC) is associated with the presence of a large EPEC adherence factor plasmid and the formation of localized adherence clusters on tissue culture cells. Three mouse monoclonal antibodies (ICA2, ICA3, and ICA4) were produced against BFP purified from EPEC B171 (O111:NM). These monoclonal antibodies reacted in immunoblots with different epitopes of the 19.5-kDa bundlin subunit of BFP of heterologous EPEC. These reagents could serve as diagnostic tools for the identification of EPEC as well as for studying the role of BfpA in the interaction of EPEC with eukaryotic cells.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.